首页> 外文期刊>Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research >Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid
【24h】

Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid

机译:低分子量透明质酸的免疫刺激和抗血管生成活性

获取原文
获取原文并翻译 | 示例
           

摘要

The immunostimulatory activities of two low molecular weight hyaluronic acids (LMWHA-1 and LMWHA-2 with MW of 1.45×105 and 4.52×104Da, respectively) and HA (MW, 1.05×106Da) were evaluated by using in vitro cell models and in vivo animal models, and their effects on angiogenesis were measured in vivo by using the chick embryo chorioallantoic membrane (CAM) assay. The results demonstrated that LMWHA-1, LMWHA-2 and HA could promote the splenocyte proliferation, increase the activity of acid phosphatase in peritoneal macrophages and strengthen peritoneal macrophages to devour neutral red in vitro in a dose-dependent manner. Furthermore, LMWHA-1 and LMWHA-2 exhibited much stronger immunostimulatory activity than HA. For assay in vivo, LMWHA-1 and LMWHA-2 significantly increased the indices of spleen and thymus, the activity of lysozyme in serum and the swelling rate of earlap in delayed-type hypersensitivity in a dose-dependent manner. In the CAM model, the results showed that LMWHA-1, LMWHA-2 and HA suppressed angiogenesis in chicken embryos. Moreover, LMWHA-1 exhibited higher antiangiogenesis activity than LMWHA-2 and HA. All these results suggested that LMWHA might be a potential natural immunomodulator and a potential candidate compound for antiangiogenic.
机译:两种低分子量透明质酸(LMWHA-1和LMWHA-2的MW分别为1.45×105和4.52×104Da)和HA(MW为1.05×106Da)的免疫刺激活性通过体外细胞模型和通过使用鸡胚绒膜尿囊膜(CAM)分析,在体内测量了体内动物模型及其对血管生成的影响。结果表明,LMWHA-1,LMWHA-2和HA可以促进脾细胞增殖,增加腹膜巨噬细胞中酸性磷酸酶的活性,并增强腹膜巨噬细胞以剂量依赖的方式吞噬中性红。此外,LMWHA-1和LMWHA-2表现出比HA强得多的免疫刺激活性。对于体内测定,LMWHA-1和LMWHA-2以剂量依赖的方式显着增加了脾脏和胸腺的指数,血清中溶菌酶的活性以及延缓型超敏反应中耳垂的溶胀率。在CAM模型中,结果表明LMWHA-1,LMWHA-2和HA抑制了鸡胚中的血管生成。而且,LMWHA-1显示出比LMWHA-2和HA更高的抗血管生成活性。所有这些结果表明LMWHA可能是潜在的天然免疫调节剂和潜在的抗血管生成候选化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号